Ameriprise Financial Inc Cytosorbents Corp Transaction History

Ameriprise Financial Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.22 $1,921 - $3,516	-1,092 Reduced 1.06%	101,645 $222,000
Q1 2022 May 16, 2022	BUY	$2.88 - $4.23 $6,698 - $9,838	2,326 Added 2.32%	102,737 $327,000
Q4 2021 Feb 14, 2022	BUY	$4.05 - $8.11 $177,928 - $356,296	43,933 Added 77.79%	100,411 $421,000
Q3 2021 Nov 15, 2021	SELL	$7.0 - $9.71 $164,115 - $227,650	-23,445 Reduced 29.33%	56,478 $459,000
Q2 2021 Aug 16, 2021	SELL	$7.55 - $9.42 $15,922 - $19,866	-2,109 Reduced 2.57%	79,923 $604,000
Q1 2021 May 17, 2021	BUY	$8.23 - $11.48 $360,819 - $503,306	43,842 Added 114.8%	82,032 $712,000
Q4 2020 Feb 12, 2021	BUY	$7.65 - $8.98 $292,153 - $342,946	38,190 New	38,190 $305,000

16.9M

10.1K

500

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $51.9M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.